Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion type Assertion NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_head.
- NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_provenance.
- NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion evidence source_evidence_literature NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_provenance.
- NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion SIO_000772 16507781 NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_provenance.
- NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion wasDerivedFrom befree-20140225 NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_provenance.
- NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_assertion wasGeneratedBy ECO_0000203 NP844298.RAEMKgjfNA6auoJVNj2JKmld7IZuDkRw2vaaacniamZ5A130_provenance.